Decorin reduces intraocular pressure and retinal ganglion cell loss in rodents through fibrolysis of the scarred trabecular meshwork

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 6, 2015, Pages 3743-3757

  Hill, Lisa J ^a   Mead, Ben ^a   Blanch, Richard J ^a,b   Ahmed, Zubair ^a   De Cogan, Felicity ^a   Morgan Warren, Peter J ^a   Mohamed, Shabbir ^a   Leadbeater, Wendy ^a   Scott, Robert A H ^a,b   Berry, Martin ^a   Logan, Ann ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Decorin; Extracellular matrix; Fibrolysis; Intraocular pressure; TGF ; Trabecular meshwork

Indexed keywords

DECORIN; MATRIX METALLOPROTEINASE;

ADULT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CONTROLLED STUDY; EVOKED VISUAL RESPONSE; EXTRACELLULAR MATRIX; FIBROSIS; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; MALE; NEUROPROTECTION; NONHUMAN; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; TRABECULAR MESHWORK FIBROSIS; ANIMAL; CELL DEATH; DRUG EFFECTS; PATHOLOGY; SPRAGUE DAWLEY RAT; TRABECULAR MESHWORK;

ANIMALS; CELL DEATH; DECORIN; FIBROSIS; INTRAOCULAR PRESSURE; MALE; RATS; RATS, SPRAGUE-DAWLEY; RETINAL GANGLION CELLS; TRABECULAR MESHWORK;

EID: 84939803226     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-15622     Document Type: Article

References (79)

1. Alvarado J, Murphy C, Juster R. Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals. Ophthalmology. 1984;91:564-579.
2. Alvarado J, Murphy C, Polansky J, Juster R. Age-related changes in trabecular meshwork cellularity. Invest Ophthalmol Vis Sci. 1981;21:714-727.
3. Grierson I, Howes RC. Age-related depletion of the cell population in the human trabecular meshwork. Eye. 1987;1: 204-210.
4. Tektas O-Y, Lütjen-Drecoll E. Structural changes of the trabecular meshwork in different kinds of glaucoma. Exp Eye Res. 2009;88:769-775.
5. Nakajima E, Nakajima T, Minagawa Y, Shearer TR, Azuma M. Contribution of ROCK in contraction of trabecular meshwork: proposed mechanism for regulating aqueous outflow in monkey and human eyes. J Pharm Sci. 2005;94:701-708.
6. Inoue T, Tanihara H. Rho-associated kinase inhibitors: a novel glaucoma therapy. Prog Retin Eye Res. 2013;37:1-12.
7. Borrás T. Gene expression in the trabecular meshwork and the influence of intraocular pressure. Prog Retin Eye Res. 2003; 22:435-463.
8. WuDunn D. Mechanobiology of trabecular meshwork cells. Exp Eye Res. 2009;88:718-723.
9. Fleenor DL, Shepard AR, Hellberg PE, Jacobson N, Pang I-H, Clark AF. TGFβ2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest Ophthalmol Vis Sci. 2006;47:226-234.
10. Lütjen-Drecoll E, Shimizu T, Rohrbach M, Rohen J. Quantitative analysis of 'plaque material' in the inner-and outer wall of Schlemm's canal in normal-and glaucomatous eyes. Exp Eye Res. 1986;42:443-455.
11. Rohen J, Lütjen-Drecoll E, Flügel C, Meyer M, Grierson I. Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma (POAG). Exp Eye Res. 1993; 56:683-692.
12. Ueda J, Wentz-Hunter K, Yue BY. Distribution of myocilin and extracellular matrix components in the juxtacanalicular tissue of human eyes. Invest Ophthalmol Vis Sci. 2002;43:1068- 1076.
13. Lütjen-Drecoll E, Futa R, Rohen J. Ultrahistochemical studies on tangential sections of the trabecular meshwork in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 1981;21: 563-573.
14. Fuchshofer R, Welge-Lussen U, Lütjen-Drecoll E. The effect of TGF-β2 on human trabecular meshwork extracellular proteolytic system. Exp Eye Res. 2003;77:757-765.
15. Han H, Kampik D, Grehn F, Schlunck G. TGF-β2-induced invadosomes in human trabecular meshwork cells. PLoS One. 2013;8:e70595.
16. Junglas B, Kuespert S, Seleem AA, et al. Connective tissue growth factor causes glaucoma by modifying the actin cytoskeleton of the trabecular meshwork. Am J Pathol. 2012;180:2386-2403.
17. Kottler UB, Jünemann AGM, Aigner T, Zenkel M, Rummelt C, Schlötzer-Schrehardt U. Comparative effects of TGF-β1 and TGF- β2 on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma. Exp Eye Res. 2005;80:121-134.
18. Leivonen S-K, Lazaridis K, Decock J, Chantry A, Edwards DR, Kähäri V-M. TGF-β-elicited induction of tissue inhibitor of metalloproteinases (TIMP)-3 expression in fibroblasts involves complex interplay between Smad3, p38α, and ERK1/2. PLoS One. 2013;8:e57474.
19. Prendes MA, Harris A, Wirostko BM, Gerber AL, Siesky B. The role of transforming growth factor β in glaucoma and the therapeutic implications. Br J Ophthalmol. 2013;97:680-686.
20. Robertson JV, Golesic E, Gauldie J, West-Mays JA. Ocular gene transfer of active TGF-β induces changes in anterior segment morphology and elevated IOP in rats. Invest Ophthalmol Vis Sci. 2010;51:308-318.
21. Robertson JV, Siwakoti A, West-Mays JA. Altered expression of transforming growth factor beta 1 and matrix metalloproteinase- 9 results in elevated intraocular pressure in mice. Mol Vis. 2013;19:684.
22. Shepard AR, Millar JC, Pang I-H, Jacobson N, Wang W-H, Clark AF. Adenoviral gene transfer of active human transforming growth factor-β2 elevates intraocular pressure and reduces outflow facility in rodent eyes. Invest Ophthalmol Vis Sci. 2010;51:2067-2076.
23. Taylor AW. Primary open-angle glaucoma: A transforming growth factor-β pathway-mediated disease. Am J Pathol. 2012;180:2201-2204.
24. Kottler UB, Jünemann AG, Aigner T, Zenkel M, Rummelt C, Schlötzer-Schrehardt U. Comparative effects of TGF-β1 and TGF-β2 on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma. Exp Eye Res. 2005;80:121-134.
25. Ochiai Y, Ochiai H. Higher concentration of transforming growth factor-β in aqueous humor of glaucomatous eyes and diabetic eyes. Jpn J Ophthalmol. 2002;46:249-253.
26. Picht G, Welge-Luessen U, Grehn F, Lütjen-Drecoll E. Transforming growth factor β2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp. 2001;239:199-207.
27. Tripathi RC, Chan WA, Li J, Tripathi BJ. Trabecular cells express the TGF-β2 gene and secrete the cytokine. Exp Eye Res. 1994;58:523-528.
28. Inatani M, Tanihara H, Katsuta H, Honjo M, Kido N, Honda Y. Transforming growth factor-β2 levels in aqueous humor of glaucomatous eyes. Graefes Arch Clin Exp. 2001;239:109- 113.
29. Gottanka J, Chan D, Eichhorn M, Lütjen-Drecoll E, Ethier CR. Effects of TGF-β2 in perfused human eyes. Invest Ophthalmol Vis Sci. 2004;45:153-158.
30. Wordinger RJ, Fleenor DL, Hellberg PE, et al. Effects of TGF-β2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma. Invest Ophthalmol Vis Sci. 2007;48:1191-1200.
31. Zhao X, Ramsey KE, Stephan DA, Russell P. Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-β. Invest Ophthalmol Vis Sci. 2004;45:4023-4034.
32. Sethi A, Mao W, Wordinger RJ, Clark AF. Transforming growth factor-β induces extracellular matrix protein cross-linking lysyl oxidase (LOX) genes in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2011;52:5240-5250.
33. Baramova E, Bajou K, Remacle A, et al. Involvement of PA/ plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation. FEBS Letters. 1997;405: 157-162.
34. Guo M-S, Wu Y-Y, Liang Z-B Hyaluronic acid increases MMP-2 and MMP-9 expressions in cultured trabecular meshwork cells from patients with primary open-angle glaucoma. Mol Vis. 2012;18:1175.
35. Borisuth N, Tripathi B, Tripathi R. Identification and partial characterization of TGF-β1 receptors on trabecular cells. Invest Ophthalmol Vis Sci. 1992;33:596-603.
36. Yang C, Houren W, Michael P, Banghong D, Zhongyu L. Apoptosis of human trabecular meshwork cells induced by transforming growth factor-β2 in vitro in vitro. J Huazhong Univ Sci Technol Med Sci. 2004;24:87-89.
37. Honjo M, Tanihara H, Inatani M, et al. Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest Ophthalmol Vis Sci. 2001;42:137-144.
38. Wiederholt M. Direct involvement of trabecular meshwork in the regulation of aqueous humor outflow. Curr Opin Ophthalmol. 1998;9:46-49.
39. Rao PV, Deng P, Sasaki Y, Epstein DL. Regulation of myosin light chain phosphorylation in the trabecular meshwork: role in aqueous humour outflow facility. Exp Eye Res. 2005;80: 197-206.
40. Honjo M, Tanihara H, Inatani M, et al. Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest Ophthalmol Vis Sci. 2001;42:137-144.
41. Van de Velde S, Van Bergen T, Sijnave D, et al. AMA0076, a novel, locally acting Rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia. Invest Ophthalmol Vis Sci. 2014;55: 1006-1016.
42. Yang C-YC, Liu Y, Lu Z, Ren R, Gong H. Effects of Y27632 on aqueous humor outflow facility with changes in hydrodynamic pattern and morphology in human eyes. Invest Ophthalmol Vis Sci. 2013;54:5859-5870.
43. Vidal-Sanz M, Salinas-Navarro M, Nadal-Nicolás FM, et al. Understanding glaucomatous damage: anatomical and functional data from ocular hypertensive rodent retinas. Prog Retin Eye Res. 2012;31:1-27.
44. Morrison JC, Johnson EC, Cepurna W, Jia L. Understanding mechanisms of pressure-induced optic nerve damage. Prog Retin Eye Res. 2005;24:217-240.
45. Almasieh M, Wilson AM, Morquette B, Vargas JLC, Di Polo A. The molecular basis of retinal ganglion cell death in glaucoma. Prog Retin Eye Res. 2012;31:152-181.
46. Dai C, Khaw PT, Yin ZQ, Li D, Raisman G, Li Y. Structural basis of glaucoma: the fortified astrocytes of the optic nerve head are the target of raised intraocular pressure. Glia. 2012;60:13- 28.
47. Botfield H, Gonzalez AM, Abdullah O, et al. Decorin prevents the development of juvenile communicating hydrocephalus. Brain. 2013;136:2842-2858.
48. Logan A, Baird A, Berry M. Decorin attenuates gliotic scar formation in the rat cerebral hemisphere. Exp Neurol. 1999; 159:504-510.
49. Schönherr E, O'Connell BC, Schittny J, et al. Paracrine or virusmediated induction of decorin expression by endothelial cells contributes to tube formation and prevention of apoptosis in collagen lattices. Eur J Cell Biol. 1999;78:44-55.
50. Seidler DG, Goldoni S, Agnew C, et al. Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation. J Biol Chem. 2006;281: 26408-26418.
51. Du S, Wang S, Wu Q, Hu J, Li T. Decorin inhibits angiogenic potential of choroid-retinal endothelial cells by downregulating hypoxia-induced Met, Rac1, HIF-1α and VEGF expression in cocultured retinal pigment epithelial cells. Exp Eye Res. 2013;116:151-160.
52. Schönherr E, Sunderkötter C, Iozzo RV, Schaefer L. Decorin, a novel player in the insulin-like growth factor system. J Biol Chem. 2005;280:15767-15772.
53. Svensson L, Heineg D. Decorin-binding sites for collagen type I are mainly located in leucine-rich repeats 4-5. J Biol Chem. 1995;270:20712-20716.
54. Ahmed Z, Bansal D, Tizzard K, et al. Decorin blocks scarring and cystic cavitation in acute and induces scar dissolution in chronic spinal cord wounds. Neurobiol Dis. 2014;64:163- 176.
55. Davies JE, Tang X, Denning JW, Archibald SJ, Davies SJ. Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries. Eur J Neurosci. 2004;19:1226-1242.
56. Nassar K, Lüke J, Lüke M, et al. The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR). Graefes Arch Clin Exp. 2011;249:1649-1660.
57. Isaka Y, Brees DK, Ikegaya K, et al. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med. 1996;2:418-423.
58. Giri SN, Hyde DM, Braun RK, Gaarde W, Harper JR, Pierschbacher MD. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem Pharmacol. 1997;54:1205-1216.
59. Minor K, Tang X, Kahrilas G, Archibald SJ, Davies JE, Davies SJ. Decorin promotes robust axon growth on inhibitory CSPGs and myelin via a direct effect on neurons. Neurobiol Dis. 2008;32:88-95.
60. Tsuruga H, Murata H, Araie M, Aihara M. A model for the easy assessment of pressure-dependent damage to retinal ganglion cells using cyan fluorescent protein-expressing transgenic mice. Mol Vis. 2012;18:2468.
61. Surey S, Berry M, Logan A, Bicknell R, Ahmed Z. Differential cavitation, angiogenesis and wound-healing responses in injured mouse and rat spinal cords. Neuroscience. 2014;275: 62-80.
62. Mead B, Thompson A, Scheven BA, Logan A, Berry M, Leadbeater W. Comparative evaluation of methods for estimating retinal ganglion cell loss in retinal sections and wholemounts. PLoS One. 2014;9:e110612.
63. Nakazawa T, Takahashi H, Nishijima K, et al. Pitavastatin prevents NMDA-induced retinal ganglion cell death by suppressing leukocyte recruitment. J Neurochem. 2007;100: 1018-1031.
64. Vigneswara V, Akpan N, Berry M, Logan A, Troy CM, Ahmed Z. Combined suppression of CASP2 and CASP6 protects retinal ganglion cells from apoptosis and promotes axon regeneration through CNTF-mediated JAK/STAT signalling. Brain. 2014; 137:1656-1675.
65. Belforte N, Sande P, de Zavalía N, Knepper PA, Rosenstein RE. Effect of chondroitin sulfate on intraocular pressure in rats. Invest Ophthalmol Vis Sci. 2010;51:5768-5775.
66. Nili N, Cheema AN, Giordano FJ, et al. Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function: potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty. Am J Pathol. 2003;163:869-878.
67. Ahmed Z, Bansal D, Tizzard K, et al. Decorin blocks scarring and cystic cavitation in acute and induces scar dissolution in chronic spinal cord wounds. Neurobiol Dis. 2014;64:163- 176.
68. Grisanti S, Szurman P, Warga M, et al. Decorin modulates wound healing in experimental glaucoma filtration surgery: a pilot study. Invest Ophthalmol Vis Sci. 2005;46:191-196.
69. Rönkkö S, Rekonen P, Kaarniranta K, Puustjärvi T, Teräsvirta M, Uusitalo H. Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma. Graefes Arch Clin Exp. 2007;245:697-704.
70. Schlötzer-Schrehardt U, Lommatzsch J, Küchle M, Konstas AGP, Naumann GOH. Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome/glaucoma and primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2003;44:1117-1125.
71. Yang J, Zhang K, Howard CP, et al. Serum matrix metalloproteinase levels and activities in patients with glaucoma. Invest Ophthalmol Vis Sci. 2003;44:102-B27.
72. Bradley JM, Kelley MJ, Rose A, Acott TS. Signalling pathways used in trabecular matrix metalloproteinase response to mechanical stretch. Invest Ophthalmol Vis Sci. 2003;44: 5174-5181.
73. De Groef L, Van Hove I, Dekeyster E, Stalmans I, Moons L. MMPs in the trabecular meshwork: promising targets for future glaucoma therapies? Invest Ophthalmol Vis Sci. 2013; 54:7756-7763.
74. Seidler DG, Schaefer L, Robenek H, Iozzo RV, Kresse H, Schönherr E. A physiologic three-dimensional cell culture system to investigate the role of decorin in matrix organisation and cell survival. Biochem Biophys Res Commun. 2005;332: 1162-1170.
75. Schönherr E, Levkau B, Schaefer L, Kresse H, Walsh K. Decorin-mediated signal transduction in endothelial cells involvement of Akt/protein kinase B in up-regulation of p21WAF1/CIP1 but not p27KIP1. J Biol Chem. 2001;276: 40687-40692.
76. Goldoni S, Iozzo RV. Tumor microenvironment: modulation by decorin and related molecules harboring leucine-rich tandem motifs. Int J Cancer. 2008;123:2473-2479.
77. Schaefer L, Macakova K, Raslik I, et al. Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am J Pathol. 2002;160:1181-1191.
78. Wu H, Wang S, Xue A, et al. Overexpression of decorin induces apoptosis and cell growth arrest in cultured rat mesangial cells in vitro. Nephrology. 2008;13:607-615.
79. Tsai JC, Wu L, Worgul B, Forbes M, Cao J. Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma. Curr Eye Res. 2005;30:1025-1031.